Filariasis
Infections with nematodes of the superfamily FILARIOIDEA. The presence of living worms in the body is mainly asymptomatic but the death of adult worms leads to granulomatous inflammation and permanent fibrosis. Organisms of the genus Elaeophora infect wild elk and domestic sheep causing ischemic necrosis of the brain, blindness, and dermatosis of the face.
Subtype terms (8)
More specific conditions that are subtypes of Filariasis in the MeSH hierarchy.
- Acanthocheilonemiasis
- Dipetalonema Infections
- Dirofilariasis
- Elephantiasis, Filarial
10 drugs (7 approved, 3 experimental)
- Loiasis
7 drugs approved
- Mansonelliasis
3 drugs approved
- Onchocerciasis
10 drugs (7 approved, 3 experimental)
- Setariasis
Drugs by status
Approved for this indication (1)
Phase 4 trials (2)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (17)
- World Health Organization
- Armauer Hansen Research Institute, Ethiopia
- Centre d'Appui à la lutte contre la Maladie
- University of London
- Emory University
- Ghana Health Services
- University of Washington
- Natural History Museum, United Kingdom
- Noguchi Memorial Institute for Medical Research
- University of Basel
- Malaria Research and Training Center, Bamako, Mali
- Bill and Melinda Gates Foundation
- Blantyre Institute for Community Ophthalmology
- Federal Ministry of Health, Ethiopia
- Government of France
- Government of Mozambique
- Christian Medical College, Vellore, India
Organization Involved with Phase 3 Indications (11)
- The Task Force for Global Health
- Centre Muraz
- Case Western Reserve University
- Lihir Medical Centre
- Colorado State University
- Neglected Tropical Disease Support Center
- Washington University in St. Louis
- United States Agency for International Development
- Government of Papua New Guinea
- Institut et Haute école de la Santé, La Source
- Regional Hospital of Agboville, Southern Cote d'Ivoire
Organization Involved with Phase 2 Indications (3)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (8)